Affairs warm: as the largest producers stentov in the country can lose business

Show original
12 years ago two graduates fizfaka Novosibirsk state university started production medical stentov for coronary vessels. Today every fifth stent, established to patients in the Russian hospitals, is released by company created by them "Angiolayn". In 2021 the enterprise earned more than billion rubles of revenue and 565 million rubles of profit. The last three years the revenue and a share in the Angiolayna market decreases because of the intra corporate conflict which Andrey Nikolaevich Kudryashov to disorder to the Novosibirsk Campus got still the teenager — arrived to study in...